Zou Chenyu, Harvard Abbey, Qian Jingjing, Fox Brent I
Department of Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, Auburn, AL, USA.
Digit Health. 2023 Jul 27;9:20552076231191050. doi: 10.1177/20552076231191050. eCollection 2023 Jan-Dec.
During the Coronavirus Disease 2019 (COVID-19) pandemic, digital health technologies (DHTs) became increasingly important, especially for older adults. The objective of this systematic review was to synthesize evidence on the rapid implementation and use of DHTs among older adults during the COVID-19 pandemic.
A structured, electronic search was conducted on 9 November 2021, and updated on 5 January 2023, among five databases to select DHT interventional studies conducted among older adults during the pandemic. The bias of studies was assessed using Version 2 of the Cochrane Risk-of-Bias Tool for randomized trials (RoB 2) and Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I).
Among 20 articles included in the review, 14 (70%) focused on older adults with chronic diseases or symptoms, such as dementia or cognitive impairment, type 2 diabetes, and obesity. DHTs included traditional telehealth interventions via telephone, video, and social media, as well as emerging technologies such as Humanoid Robot and Laser acupuncture teletherapy. Using RoB 2 and ROBINS-I, four studies (20%) were evaluated as high or serious overall risk of bias. DHTs have shown to be effective, feasible, acceptable, and satisfactory for older adults during the COVID-19 pandemic compared to usual care. In addition, some studies also highlighted challenges with technology, hearing difficulties, and communication barriers within the vulnerable population.
During the COVID-19 pandemic, DHTs had the potential to improve various health outcomes and showed benefits for older adults' access to health care services.
在2019年冠状病毒病(COVID-19)大流行期间,数字健康技术(DHTs)变得越来越重要,尤其是对老年人而言。本系统评价的目的是综合关于COVID-19大流行期间老年人快速实施和使用DHTs的证据。
于2021年11月9日进行了结构化电子检索,并于2023年1月5日更新,在五个数据库中筛选大流行期间在老年人中开展的DHT干预研究。使用Cochrane随机试验偏倚风险工具第2版(RoB 2)和干预性非随机研究中的偏倚风险(ROBINS-I)评估研究的偏倚。
纳入该评价的20篇文章中,14篇(70%)关注患有慢性病或有相关症状的老年人,如痴呆或认知障碍、2型糖尿病和肥胖症。DHTs包括通过电话、视频和社交媒体进行的传统远程医疗干预,以及人形机器人和激光针灸远程治疗等新兴技术。使用RoB 2和ROBINS-I评估,四项研究(20%)被评定为总体偏倚风险高或严重。与常规护理相比,在COVID-19大流行期间,DHTs已证明对老年人有效、可行、可接受且令人满意。此外,一些研究还强调了弱势群体中存在的技术问题、听力困难和沟通障碍。
在COVID-19大流行期间,DHTs有改善各种健康结局的潜力,并显示出对老年人获得医疗保健服务有益。